CHARLOTTE, N.C.–(BUSINESS WIRE)–AOM Infusion (“AOM” or “the Company”), a leading specialty infusion provider focused on intravenous immunoglobulin (“IVIG”), chronic inflammatory (CID) and specialty infusion therapy, today announced that Keyur Mehta has been named Chief Executive Officer. Christopher York will continue in his position as Chairman of the Company. Mr. Mehta brings more than 25 years … [Read more…]
Poster presentations to include insights on paths toward diagnosis and disease modifying therapies in patients facing Myasthenia Gravis, Alzheimer’s Disease, and Multiple Sclerosis SAN FRANCISCO–(BUSINESS WIRE)–#ISPORannual–PicnicHealth, a patient-centered health technology company, today announced the presentation of three abstracts to be presented at ISPOR 2023 from the company’s neurology-focused research programs. The poster presentations leverage previously … [Read more…]
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc®, a digital health leader revolutionizing chronic care, today announced that it has been selected as “Best Overall Digital Health Company” in the 7th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization … [Read more…]
This is the fourth consecutive year WellSky has been recognized in the prestigious international awards program for standout digital health and medical technology companies OVERLAND PARK, Kan.–(BUSINESS WIRE)–WellSky, a leading health and community care technology company, today announced that WellSky CareInsights for Hospice has been selected as “Best Predictive Analytics Solution” in the seventh annual … [Read more…]
Single-arm trial will evaluate an accelerated dosing schedule BURLINGTON, Mass.–(BUSINESS WIRE)–PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, today announced that the first patients are now being dosed in ECLIPSE PV, a … [Read more…]
Partnership Reinforces USHV’s Position as a Leading Cardiovascular Practice Management Organization and Will Drive Efforts to Transform How Quality Cardiovascular Care Is Delivered NASHVILLE, Tenn.–(BUSINESS WIRE)–US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, announced today that it has entered into an agreement with Rubicon Founders (“Rubicon”), a … [Read more…]
Provides NImmune access to NIMML’s TITAN-X advanced computational modeling and A.I. platform to accelerate biomarker-driven clinical development of its LANCL immunoregulatory drug pipeline NImmune will commit up to $15 million in R&D funding for the precision medicine collaboration with NIMML for advancing the LANCL drug pipeline BLACKSBURG, Va.–(BUSINESS WIRE)–NImmune Biopharma (“NImmune”), a late-clinical-stage precision immunology … [Read more…]
– Successfully Met Goals Outlined in MassBio’s Diversity, Equity, and Inclusion (DE&I) Industry Pledge – – New Disclosures of Company’s Impact on Planet—Including Multiyear Data on Scope 1, Scope 2, and Select Scope 3 Greenhouse Gas (GHG) Emissions – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today published its 2022 … [Read more…]
The behavior change app will be available to eligible members as part of the CareFirst WellBeing℠ Program. NEW YORK–(BUSINESS WIRE)–Noom for Work, the commercial leader in behavior change, announced today that it would deliver two new preventive health solutions to commercial members of CareFirst BlueCross BlueShield’s (CareFirst): Noom Weight and Noom’s Diabetes Prevention Program. Beginning … [Read more…]
RADNOR, Pa.–(BUSINESS WIRE)–Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will present and participate during the following conferences in May. JMP Securities 2023 Life Sciences Conference in New York, NY May 15 at 3:30 p.m. E.T. RBC Annual Healthcare Conference … [Read more…]
